The Eurasian Economic Union (EAEU) is an economic union of states located primarily in northern Eurasia. A treaty aiming for the establishment of the EAEU was signed on 29 May 2014 by the leaders of Belarus, Kazakhstan and Russia, and came into force on 1 January 2015. Treaties aiming for Armenia’s and Kyrgyzstan’s accession to the Eurasian Economic Union were signed on 9 October and 23 December 2014, respectively. Armenia’s accession treaty came into force on 2 January 2015. Kyrgyzstan’s accession treaty came into effect on 6 August 2015. It participated in the EAEU from the day of its establishment as an acceding state.

EEC Intends to Extend Transition Period for Re-Registration of Medical Devices

The Eurasian Economic Commission of the Eurasian-Asian Economic Union (EAEU) intends to extend the transition period for re-registration of medical devices with a registration certificate in their cou...

First Results of EAEU Member Countries’ Pharmaceutical Inspectorates Cooperation

Not only pharmaceutical companies of the EAEU member countries are reaching after obtaining an EAEU GMP certificate – the process is starting to involve foreign pharmaceutical manufacturers as well. T...

Pharma Forum of EAEU and CIS was Held in Moscow

In Radisson, Moscow, the Хth Pharmaceutical Forum of the EAEU and CIS countries is ongoing. In the morning, regulators of the EAEU member-countries have been looking for reasons why there are only 28 ...

Mutual Recognition of GMP Certificates in EAEU

In Sochi, within the «Healthy Life. On the Way to Target 80+» Forum, a session under the topic «The system of universal health coverage as a key to achieving the national target» was held. How much...

EAEU’s pharma regulatory landscape was discussed at the VI All-Russia Congress

Participants of the VI All-Russia Congress "Pharmaceutical activities in Russia and the EAEU" discussed the regulatory framework of pharmaceutical activities in Russia and within the EAEU.

‘SID & GP’ experts attended the VI international forum “Anti-counterfeit 2018...

The representatives of the State Institute of Drugs and Good Practices of Minpromtorg of Russia took part in the International Forum «Anti-counterfeit 2018» in Moscow (Russia).

Data integrity was discussed at the ‘Pharmtech & Ingredients’ exhibition

On 20 November, at the exhibition "Pharmtech & Ingredients", held in Crocus Expo (Moscow), the panel discussion on the topic "Data integrity management: key aspects" was organized.

‘RegLek-2018’ conference participants discussed issues in drug evaluation

On 19th November the scientific-practical conference 'RegLek-2018', was held in Moscow. Participants of the event discussed the modern approaches to drugs expert evaluation.

St. Petersburg hosts 8th annual forum “Life Sciences Invest. Partnering Russia”

life sciences forum
The VIII annual international partnering-forum "Life Sciences Invest. Partnering Russia" started in St. Petersburg. The first day of the Forum brought together nearly 650 people. The key discussion...

The Director of FSI ‘SID & GP’ participated in the XI Eurasian Economic Forum

The Director of the Russian Federal State-funded Institution “State Institute of Drugs and Good Practices”, Vladislav Shestakov, took part in the XI Eurasian Economic Forum.

SID&GP discussed Russian legislation harmonization with EAEU law

The Director of FSI "SID&GP" took part in the round-table discussion on the topic "The issues of Russian legislation harmonization with EAEU law".

SID&GP representatives participated in GEP-Russia 2018

On October 16, representatives of FSI "State Institute of Drugs and Good Practices" (SID&GP) took part in the GEP-Russia International Conference in Moscow (Russia).

EAEU opens pharma market for foreign manufacturers

Prospective entry into the market of the EAEU of foreign medicinal products registered according to the national procedures of the EAEU States were discussed by the Member of the Board.

SID&GP participated in PIC/S Committee meeting

Tatyana Nikolko, Deputy Head of the Administration for Pharmaceutical Products Inspection and Evaluation took the floor with a presentation on the Russian GMP Inspectorate.

EEC approved a number of documents for the common market of medicines

The College of the Eurasian Economic Commission (EEC) approved the Guidance on Analytical Method Validation and adopted the Guidance on General Issues of Clinical Trials.

Conducting a joint training GMP-inspection

On June 4 and 5, 2018 employees of FSI “SID & GP”conducted a joint training GMP inspection with representatives of the regulatory entities of the Republic of Kazakhstan and the Kyrgyz Republic.